Joshua Blacher
Director of Finance/CFO bij PREDICTIVE ONCOLOGY INC.
Profiel
Joshua Blacher is currently the Chief Financial Officer at Predictive Oncology, Inc. since 2023.
He is also working as a Consultant at Danforth Advisors LLC since 2022.
In 2019, he became the Managing Partner at Columbus Circle Capital, LLC.
Additionally, he holds the position of Chief Financial Officer at Rna Disease Diagnostics, Inc. since 2021.
In his former roles, Mr. Blacher worked as a Principal at Morgan Stanley.
From 2011 to 2014, he served as the Executive Vice President-Corporate Development at WFW Cardiac, Inc. He also held the position of Principal at the Federal Reserve Bank of New York.
Mr. Blacher was the Chief Financial Officer & Executive Vice President at Vestopia, Inc. He served as the Chief Financial Officer at SciSparc Ltd.
from 2017 to 2018.
In 2022, he briefly worked as the Chief Financial & Accounting Officer at LogicBio Therapeutics, Inc. From 2018 to 2019, he held the role of Chief Business Officer at InMed Pharmaceuticals, Inc. Mr. Blacher was also the Chief Financial Officer at SciSparc Ltd.
from 2017 to 2018.
Lastly, from 2014 to 2017, he served as the Chief Financial Officer at Galmed Pharmaceuticals Ltd.Mr. Blacher completed his undergraduate studies at Yeshiva University.
He furthered his education by obtaining an MBA from Columbia Business School.
Actieve functies van Joshua Blacher
| Bedrijven | Functie | Begin |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Director of Finance/CFO | 30-09-2023 |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Corporate Officer/Principal | 01-09-2022 |
| Columbus Circle Capital, LLC | Corporate Officer/Principal | 01-08-2019 |
Rna Disease Diagnostics, Inc.
 Rna Disease Diagnostics, Inc. Packaged SoftwareTechnology Services RNA Disease Diagnostics is a Canadian company that aims to create a molecular diagnostic technology platform to prevent infectious disease transmission and improve global health. The private company is based in Toronto, Canada. The company plans to use its proprietary antisense RNA diagnostic platform to develop accurate, quick, affordable, and minimally invasive disease diagnostic testing kits for multiple diseases. RNA Disease Diagnostics' initial focus is on deploying COVID-19 antisense diagnostic point of care and home use test rapid diagnostic testing kits. The company was founded by Allan Grant Oberman. | Director of Finance/CFO | 01-09-2021 |
Eerdere bekende functies van Joshua Blacher
| Bedrijven | Functie | Einde |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Director of Finance/CFO | 16-11-2022 |
| INMED PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-08-2019 |
| SCISPARC LTD. | Director of Finance/CFO | 01-04-2018 |
| GALMED PHARMACEUTICALS LTD. | Director of Finance/CFO | 01-03-2017 |
WFW Cardiac, Inc.
 WFW Cardiac, Inc. Medical/Nursing ServicesHealth Services WFW Cardiac, Inc. provides ambulatory cardiac monitoring and diagnostic services. Its services are used by physicians to monitor electrocardiographic data (cardiac events) for patients who are suspected of having heart rhythm disorders (cardiac arrhythmias) that often precede serious complications associated with cardiovascular disease or other conditions. The company is headquartered in Buffalo Grove, IL. | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Joshua Blacher
| Yeshiva University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| MORGAN STANLEY | Finance |
| INMED PHARMACEUTICALS INC. | Health Technology |
| SCISPARC LTD. | Health Technology |
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| GALMED PHARMACEUTICALS LTD. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
WFW Cardiac, Inc.
WFW Cardiac, Inc. Medical/Nursing ServicesHealth Services WFW Cardiac, Inc. provides ambulatory cardiac monitoring and diagnostic services. Its services are used by physicians to monitor electrocardiographic data (cardiac events) for patients who are suspected of having heart rhythm disorders (cardiac arrhythmias) that often precede serious complications associated with cardiovascular disease or other conditions. The company is headquartered in Buffalo Grove, IL. | Health Services |
| Federal Reserve Bank of New York | Government |
Vestopia, Inc.
 Vestopia, Inc. Internet Software/ServicesTechnology Services Vestopia, Inc. provides online financial and market information services. It engages in evolving programs close the gap between insiders and everyday people by offering inside knowledge, information, news, and tips. The company was founded by Guy Hirsch and is headquartered in San Francisco, CA. | Technology Services |
Danforth Advisors LLC
Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Finance |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
| Columbus Circle Capital, LLC | |
Rna Disease Diagnostics, Inc.
Rna Disease Diagnostics, Inc. Packaged SoftwareTechnology Services RNA Disease Diagnostics is a Canadian company that aims to create a molecular diagnostic technology platform to prevent infectious disease transmission and improve global health. The private company is based in Toronto, Canada. The company plans to use its proprietary antisense RNA diagnostic platform to develop accurate, quick, affordable, and minimally invasive disease diagnostic testing kits for multiple diseases. RNA Disease Diagnostics' initial focus is on deploying COVID-19 antisense diagnostic point of care and home use test rapid diagnostic testing kits. The company was founded by Allan Grant Oberman. | Technology Services |
